AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 20.17 USD -2.8% Market Closed
Market Cap: 608.7m USD
Have any thoughts about
AnaptysBio Inc?
Write Note

AnaptysBio Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AnaptysBio Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
AnaptysBio Inc
NASDAQ:ANAB
Retained Earnings
-$737.5m
CAGR 3-Years
-37%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$25.5B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$30.8B
CAGR 3-Years
22%
CAGR 5-Years
36%
CAGR 10-Years
71%

See Also

What is AnaptysBio Inc's Retained Earnings?
Retained Earnings
-737.5m USD

Based on the financial report for Sep 30, 2024, AnaptysBio Inc's Retained Earnings amounts to -737.5m USD.

What is AnaptysBio Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-27%

Over the last year, the Retained Earnings growth was -29%. The average annual Retained Earnings growth rates for AnaptysBio Inc have been -37% over the past three years , -27% over the past five years .

Back to Top